AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
--------------------------------------------------------------------
Source: CNBC
Published: 2026-09-08 21:45 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
AstraZeneca on Tuesday released full results from two successful late-stage trials on its experimental drug for chronic obstructive pulmonary disease, boosting hopes that it could generate multibillion-dollar sales for the company.
--------------------------------------------------------------------